Correlation Between Genovate Biotechnology and First Insurance

Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and First Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and First Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genovate Biotechnology Co and First Insurance Co, you can compare the effects of market volatilities on Genovate Biotechnology and First Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of First Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and First Insurance.

Diversification Opportunities for Genovate Biotechnology and First Insurance

-0.59

Correlation Coefficient

Genovate Biotechnology  First Insurance

Excellent diversification

The 3 months correlation between Genovate and First is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and First Insurance Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Insurance and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with First Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Insurance has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and First Insurance go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and First Insurance

Assuming the 90 days trading horizon Genovate Biotechnology Co is expected to under-perform the First Insurance. But the stock apears to be less risky and, when comparing its historical volatility, Genovate Biotechnology Co is 1.23 times less risky than First Insurance. The stock trades about -0.05 of its potential returns per unit of risk. The First Insurance Co is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  2,255  in First Insurance Co on September 14, 2024 and sell it today you would earn a total of  295.00  from holding First Insurance Co or generate 13.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

Genovate Biotechnology Co  vs.  First Insurance Co

Genovate Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genovate Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Genovate Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

First Insurance

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in First Insurance Co are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, First Insurance showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Genovate Biotechnology and First Insurance

The main advantage of trading using opposite Genovate Biotechnology and First Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, First Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Insurance will offset losses from the drop in First Insurance's long position.

The idea behind Genovate Biotechnology Co and First Insurance Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.